France to Reduce Reimbursement Rates for Medicines in 2025

The French government plans to cut medication reimbursement by 5% to address a projected budget deficit.

The reduction in reimbursement rates for medications and medical consultations will be implemented through a ministerial decree.
This decision aims to address a €1.2 billion overspend in medication expenses for 2024, attributed to an underestimation of costs related to an aging population and innovative drugs.
The financial burden will shift partially to complementary health insurance, which may lead to higher premiums for policyholders.
Critics, including patient advocacy groups and the pharmaceutical industry, warn that the measure could exacerbate health inequalities.
The government seeks to achieve €5 billion in health spending cuts, including price reductions for health products and efficiency measures in hospitals and outpatient care.